There is an increased risk of second primary malignancies in patients with newly-diagnosed multiple myeloma who received Revlimid (lenalidomide), according to FDA.
Bristol-Myers Squibb announced three-year overall survival data from CheckMate-017 and CheckMate-057, two pivotal phase III randomized studies evaluating Opdivo versus docetaxel in patients with previously treated metastatic non-small cell lung cancer.
Returning to Houston for a town hall meeting at MD Anderson on Sept. 27, Peter Pisters, the institution's freshly-appointed president, hit every note a guy in his position needed to hit: baseball, football, shared values, shared governance, book clubs, reminiscences on growing up nerdy in Canada, the story of how he met his wife, anecdotes from taking care of MD Anderson patients during Hurricane Rita.
To detect high-grade precancerious cervical lesions and cervical cancer, women ages 30 to 65 may no longer need to rely on co-testing, and can choose to either screen for high-risk human papillomavirus types or undergo cervical cytology, according to a recent draft recommendation released by the U.S. Preventive Services Task Force.
Funaro is a resident at Duke Pharmacy, Friedman is the James B. Powell Professor of Pediatric Oncology at Duke, and Weant is a clinical pharmacist in neuro-oncology at Duke Pharmacy.
CancerCare is offering direct financial assistance to cancer patients residing in the U.S., including Puerto Rico and the U.S. Virgin Islands, who have been impacted by Hurricanes Harvey, Irma, Jose, or Maria.
Research!America's 22nd annual Advocacy Awards will pay a tribute to John Edward Porter, Research!America chair emeritus, for his decades-long commitment to advancing medical and health research. Porter served as a House member representing the 10th district in Illinois from 1980 to 2001, during which time he chaired the House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies.
Philadelphia philanthropist Concetta “Chet” Greenberg has made a gift to create the Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center.
Linus Chuang was named as chairman of obstetrics and gynecology at Western Connecticut Health Network.
FDA approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient's hormones. Verzenio, sponsored by Eli Lilly, is approved to be given in combination with an endocrine therapy, called fulvestrant, after the cancer had grown on endocrine therapy. It is also approved to be given on its own, if patients were previously treated with endocrine therapy and chemotherapy after the cancer had spread.
